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Phagocytic defenses are critical for effective host defenses against the opportunistic fungal pathogen Aspergillus
fumigatus. Previous studies found that following challenge with A. fumigatus, Toll-like receptor 9 (TLR9) knockout
mice survived longer than wild-type mice. However, the mechanism responsible was not defined. Here we demon-
strate that A. fumigatus contains unmethylated CpG sequences, the natural ligands for TLR9. A. fumigatusDNA and
synthetic CpG-rich oligodeoxynucleotides (ODNs) containing sequences found in the A. fumigatus genome potently
stimulated the production of proinflammatory cytokines in mouse bone marrow-derived dendritic cells (BMDCs)
and human plasmacytoid dendritic cells. The response was decreased when the fungal DNA was treated with a CpG
methylase or with CpG-specific endonucleases. A role for TLR9 was demonstrated as cytokine production was
abolished in BMDCs from TLR9-deficient mice. Moreover, transfection of HEK293 cells with human TLR9
conferred responsiveness to synthetic CpG-rich ODNs containing sequences found in A. fumigatus DNA. Taken
together, these data demonstrate that TLR9 detects A. fumigatusDNA, resulting in the secretion of proinflammatory
cytokines, which may contribute to the immune response to the pathogen.
Aspergillus fumigatus is a widely distributed opportunistic
fungal pathogen. Exposure generally occurs when airborne
spores (conidia) are inhaled into the lungs or sinuses (27).
While inhalation of conidia rarely causes disease in the normal
host, immunocompromised persons are prone to develop in-
vasive aspergillosis (9). Despite new additions to the antifungal
armamentarium, mortality rates in those with established dis-
ease exceed 50 percent (9). Clinical and experimental studies
have demonstrated that the innate immune responses of
phagocytes are essential for effective host defenses against A.
fumigatus (27, 31).
A critical component of innate defenses is the ability of
phagocytes to recognize structurally unrelated and evolution-
arily conserved microbial constituents referred to as “patho-
gen- (or pattern-) associated molecular patterns” (PAMPs)
(1). Among the receptors that recognize PAMPs are the mam-
malian Toll-like receptors (TLRs), a family of at least 12 mem-
bers that initiate signaling pathways through a series of adaptor
proteins, including MyD88, TIRAP/MAL, TRIF, and TRAM.
This results in activation of downstream signaling pathways
and the subsequent production of inflammatory cytokines and
the initiation of adaptive immune responses. Some TLRs, in-
cluding TLR1, TLR2, TLR4, TLR5, and TLR6, are primarily
expressed on the plasma membrane where they recognize spe-
cific molecules on the surfaces of microbes, including fungi (1,
18). Others, including TLR3, TLR7, TLR8, and TLR9, are
found in intracellular compartments and signaling responses
require ligand internalization (1, 16).
TLR9 is activated by DNA rich in unmethylated CpG mo-
tifs, whereas DNA lacking such sequences is either inert or in-
hibitory (17). Studies using CpG-containing oligodeoxynucleo-
tides (ODNs) have defined sequences that stimulate immune
responses (14). The optimal CpG motif appears to be GACGTT
for mice and GTCGTT for humans. The number of CpG motifs
and the spacing of the motifs also influence immunostimulatory
capacity. A-class CpG-containing ODNs strongly stimulate plas-
macytoid dendritic cell (pDC) alpha interferon (IFN-) re-
sponses but poorly induce B-cell proliferation (14). In contrast,
ODNs of the B class are weak inducers of pDC IFN- but strong
inducers of B-cell proliferation. C-class ODNs have intermediate
effects.
In the human, TLR9 is found mainly on pDCs and B cells.
In contrast, the cellular distribution of TLR9 in the mouse is
much broader and includes myeloid dendritic cells, pDCs,
monocytes, macrophages, and B cells. Clinical trials of CpG
DNA, used as an adjuvant in vaccines and as part of treatment
for infectious diseases and neoplasms, are ongoing (12). Orig-
inally, TLR9 was thought to be specific for bacterial and viral
DNA (both of which are rich in unmethylated CpG motifs).
However, recent studies have suggested a role for TLR9 in the
recognition of eukaryotic DNA. Mammalian DNA, when com-
plexed with anti-DNA antibodies, is a potent self-antigen for
TLR9 and may play a role in promoting systemic lupus ery-
thematosus and other autoimmune diseases (2). Moreover,
TLR9-dependent stimulation of murine DC by malarial DNA
has been demonstrated (24).
A possible role for TLR9 in host defenses against fungal
infections was suggested by Bellocchio et al. (3, 4). TLR9/
mice paradoxically survived longer than wild-type (WT) mice
* Corresponding author. Mailing address: 364 Plantation Street,
LRB317, Worcester, MA 01605. Phone: (508) 856-1525. Fax: (508) 856-
1828. E-mail: stuart.levitz@umassmed.edu.
† Supplemental material for this article may be found at http://iai
.asm.org/.
 Published ahead of print on 10 March 2008.
2123
 at UNIV O
F M
ASS M
ED SCH on Novem
ber 22, 2009 
iai.asm
.org
D
ow
nloaded from
 
following challenge with Candida albicans hyphae and A. fu-
migatus conidia. Compared with WT mice, the TLR9/ mice
had an organ fungal burden that was significantly lower and a
shift in Th1/Th2 reactivity in favor of Th2 cells. Moreover, the
TLR9/ mice infected with A. fumigatus had a markedly
reduced inflammatory response in the lungs. These data led us
to hypothesize that fungal DNA contains unmethylated CpG
motifs capable of stimulating TLR9 and thereby influencing
the host response to fungal challenge. Here we demonstrate
that DNA obtained from A. fumigatus stimulates TLR9-depen-
dent responses in human and murine cells.
MATERIALS AND METHODS
Reagents. Reagents, unless otherwise stated, were obtained from Sigma-Al-
drich (St. Louis, MO). Dulbecco’s minimal essential media and RPMI 1640
media were obtained from Gibco (Invitrogen, Carlsbad, CA). Low-endotoxin
fetal bovine serum (FBS) was obtained from Tissue Culture Biologicals (Tulare,
CA). R10 media consisted of RPMI 1640 supplemented with 100 U/ml penicillin,
100 U/ml streptomycin, 2 mM L-glutamine, 50 M -2-mercaptoethanol, and
10% heat-inactivated FBS. Escherichia coli K-12 DNA containing undetectable
levels of endotoxin was purchased from Invivogen (San Diego, CA). ODNs (see
Table S1 in the supplemental material) based upon the sequences found in the
A. fumigatus genome were synthesized on a phosphothiorate backbone by Alpha
DNA (Canada). Stimulatory CpG 1826, CpG 2007, and CpG 2336 ODNs and
control GpC 2137 and GpC 2243 ODNs with phosphothiorate linkages were
purchased from Coley Pharmaceuticals (Wellesley, MA).
Genomic DNA preparation. DNA was obtained from two strains of A. fumi-
gatus. Strain Af293 was obtained from the Fungal Genetic Stock Center (University
of Missouri, Kansas City, MO). The genome of this strain has been sequenced
(23). The other strain of A. fumigatus used was a clinical isolate (21). The data
shown are with DNA from strain Af293, except for Fig. 2, for which DNA from
the clinical isolate was utilized. In preliminary studies, the two sources of DNA
stimulated similar quantities of cytokines (data not shown). A. fumigatus was
grown on minimal liquid media consisting of yeast extract supplemented with
2.5% glucose and 3.4 g/liter yeast nitrogen base supplemented with ammonium
sulfate and amino acids at 37°C for 40 to 48 h. Fungi were harvested through a
nylon mesh filter and washed with Tris-sodium-EDTA (0.05 M Tris-HCl, pH 8.0,
0.150 M NaCl, 0.1 M EDTA, pH 8) (28). Subsequently, hyphae were freeze-dried
and ground to a powder, and the DNA was extracted with chloroform/isopro-
panol. The DNA was treated with 20 g/ml of RNase B and 20 g/ml of
proteinase K and further extracted with ethanol. Extracted fungal DNA was
purified over a cesium chloride gradient by centrifugation at 30,000 rpm (Beck-
man Ultracentrifuge L8-80 M) for 40 h at 20°C. Purified DNA collected from the
gradient was extracted with saturated N-butanol and further extracted by ethanol
extraction. DNA was then tested for the presence of glucans and endotoxin using
a Limulus amebocyte lysate test (Cape Cod Associates). Endotoxin levels were
found to be 0.03 endotoxin units/g of DNA.
Enzyme treatment of DNA. Isolated genomic A. fumigatus DNA was subjected
to CpG methylation using the CpG methyltransferase M.SssI (NEB). The meth-
ylation reaction was performed following the manufacturer’s instructions. In
addition, DNA that was either methylated or untreated was subjected to cleavage
at CpG sequences by restriction enzyme digestion with the isoschizomers MspI
or HpaII. Restriction digestion was confirmed by 1% agarose gel electrophoresis
of the treated and untreated samples. The sizes of the resulting digested DNA
fragments were compared to a DNA ladder (NEB).
Mice. All mice were specific pathogen free and housed in the University of
Massachusetts Medical Center animal facility. C57BL/6J mice were purchased
from Jackson Laboratories (Bar Harbor, ME). The TLR9-deficient mice were
obtained from Robert Finberg (UMass Medical School), who obtained the mice
from Shizuo Akira (Osaka, Japan). The knockout mice were backcrossed 12
times to a C57BL/6 background.
Generation and stimulation of BMDCs. Bone marrow-derived dendritic cells
(BMDCs) were obtained according to the protocol of Lutz et al. (20) and as in our
previous studies (11, 22, 33). Briefly, mice were euthanized and bone marrow cells
were harvested from the femurs and tibiae. After treatment with red blood cell
lysis buffer, the remaining cells were suspended at a final density of 1  106
cells per ml in R10 media supplemented with 10% supernatant from J558L cells
(as a source of granulocyte-macrophage colony-stimulating factor). Cells were
seeded in non-tissue-culture-treated petri dishes and incubated at 37°C in air
supplemented with 5% CO2. The media were changed every 3 days. On day 8 or
9, cells were harvested and the BMDCs were positively selected on a magnetic
column using CD11c-coated magnetic beads, as per the manufacturer’s instruc-
tions (Miltenyi Biotech).
BMDCs (2  105 cells per well) were added to 48-well plates containing a final
volume of 500 l media (R10 with 10% J558L supernatant). BMDCs were
transfected with DNA using 30 g/ml of N-[1-(2,3-dioloyloxy)propyl-N,N,N-
trimethylammonium methylsulfate] (DOTAP; Roche) according to the manu-
facturer’s instructions. Briefly, DNA and DOTAP were mixed together in
HEPES-buffered saline and incubated for 15 min at 25°C. The DNA-DOTAP
complexes were then added to BMDCs and further mixed by pipetting. Treated
cells were incubated for 24 h at 37°C in air supplemented with 5% CO2. Super-
natants were collected and cytokine production was analyzed for tumor necrosis
factor alpha (TNF-) and interleukin 12p70 (IL-12p70) by enzyme-linked im-
munosorbent assay (ELISA) according to the manufacturer’s instructions (eBio-
science, San Diego, CA).
Isolation and stimulation of human pDCs. pDCs were isolated as described
previously (32). Briefly, peripheral blood was obtained by venipuncture following
informed consent from healthy volunteers using a protocol approved by the
University of Massachusetts Medical Center Institutional Review Board. Blood
was anticoagulated with heparin and diluted 1:1 with Hanks balanced salt solu-
tion (BioWhittaker, Walkersville, MD), and the peripheral blood mononuclear
cells (PBMCs) were collected following Ficoll-Hypaque (Lymphoprep, West-
bury, NY) density gradient centrifugation. Human pDCs were positively selected
from the PBMCs using CD304-coated magnetic beads according to the manu-
facturer’s instructions (Miltenyi Biotec, Auburn, CA).
pDCs (5  104) were stimulated with DNA-DOTAP complexes in 96-well
flat-bottom plates containing a final volume of 200 l RPMI 1640 supplemented
with 10% fetal calf serum and 10 ng/ml recombinant IL-3 (R&D Systems,
Minneapolis, MN). After 20 h of culture in a 37°C/5% CO2 incubator, superna-
tants were collected and human IFN- levels were measured using a commer-
cially available ELISA kit (Bender MedSystems module set; Burlingame, CA).
Samples were assayed in duplicate at dilutions that fell within the range of the
standard curves.
Luciferase assay. HEK293 cells stably transfected with human TLR9 (hTLR9)
and an NF-B-driven luciferase construct (HEK/hTLR9/NF-B) and HEK293
cells stably transfected with hTLR7 and an NF-B luciferase construct (HEK/
hTLR7/NF-B) were a gift from the Eisai Research Institute (Andover, MA).
Cells were maintained in tissue culture flasks containing Dulbecco’s minimal
essential media supplemented with 10% FBS. Cells were treated with the ODNs
at the specified concentrations at a final volume of 150 l/well and incubated at
37°C in air supplemented with 5% CO2 for 18 h. Luciferase activity in cell lysates
was measured using a Steady Glo luciferase assay system (Promega, Madison,
WI) on a luminometer (Envision; Perkin Elmer).
Genome-wide scanning for GC content, CpG dinucleotides, and TLR9 stim-
ulatory sequences. Both mouse- and human-like motifs were searched for in both
DNA strands of the assembled contigs (AF.contigs.031704; release date 12 May
2007) downloaded from the Sanger ftp site (ftp://ftp.sanger.ac.uk/pub/pathogens/
A_fumigatus). Sequences matching the following patterns were selected: human
like, [CT][CT]GTCGTTN(0,4)GTCGTT; and mouse like, [CT][CT]GACGTTN
(0,4)GACGTT. Residues in brackets indicate ambiguities acceptable in the spec-
ified positions, N indicates any nucleotide, and the numbers in parentheses
indicate the number of times residues can appear in that position. Mismatches
were allowed only at the eighth or the last position. GC content was calculated
from the number of G’s and C’s found for one strand divided by the number of
base pairs sequenced. CpG dinucleotides were found when searching both
strands, and the frequency was calculated using two times the number of base
pairs sequenced. The “fuzznuc” algorithm (EMBOSS program; http://bioweb
.pasteur.fr/seqanal/EMBOSS) was used for each of the searches.
Statistical analysis. Means  standard errors (SE) were analyzed by one-way
or two-way analysis of variance (ANOVA) using a statistical software package
(GraphPad Prism 4.02; GraphPad Software, San Diego, CA). Pairs of group
means were then compared by Bonferroni’s multiple comparison test. Statistical
significance was defined as P of 	0.05.
RESULTS
A. fumigatus contains unmethylated CpG DNA. We sought
to determine if genomic DNA extracted from A. fumigatus
contained unmethylated CpG motifs. DNA was treated with
HpaII and MspI. These two endonucleases cleave DNA con-
taining the sequence 5
 . . . CCGG . . . 3
. However, they differ
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in that HpaII only cleaves unmethylated CpG sequences
whereas MspI cleaves both methylated and unmethylated CpG
sequences. Both HpaII and MspI cleaved A. fumigatus DNA
(Fig. 1). To demonstrate the specificity of the cleavage reac-
tion, the DNA was treated with the CpG methyltransferase
M.SssI prior to restriction enzyme digestion. Methylation abol-
ished the capacity of HpaII but not MspI to cleave the DNA.
These results demonstrate that A. fumigatus DNA contains
unmethylated CpG sequences.
A. fumigatus induces TNF- and IL-12p70 production in
mouse BMDCs. In order to determine if A. fumigatus DNA
was immunostimulatory, we measured TNF- and IL-12p70
release following incubation of the DNA with BMDCs. Cells
treated with the fungal DNA potently stimulated production of
both cytokines, with concentrations observed similar to those
seen following stimulation with E. coli DNA and the synthetic
ODN CpG 1826 (Fig. 2). However, when the cells were treated
with enzymatically methylated A. fumigatus DNA, the cytokine
response was nearly completely abolished. Similarly, treatment
of the DNA with the CpG-specific endonucleases HpaII and
MspI potently reduced cytokine production.
A. fumigatus DNA stimulates TNF- secretion in a TLR9-
dependent manner. Given the role of TLR9 as an intracellular
sensor of unmethylated CpG-rich DNA, we next compared
cytokine responses of BMDCs derived from WT and TLR9/
mice following stimulation with A. fumigatus DNA. In the
BMDCs from WT mice, native DNA stimulated TNF- re-
lease in a dose-dependent manner (Fig. 3). Methylated DNA
also induced TNF- production, although lower levels were
FIG. 1. A. fumigatus DNA contains unmethylated CpG sequences.
Genomic DNA was isolated from A. fumigatus and left untreated or
treated with the indicated enzymes. “” indicates treatment; “”
indicates absence of treatment. The digest was then analyzed by 1%
agarose gel electrophoresis with ethidium bromide staining. The left
lane shows a DNA ladder with numbers indicating the size of the
DNA, in kb. The figure is representative of 12 individual experiments,
each with similar results.
FIG. 2. Stimulation of murine BMDCs by A. fumigatus DNA. BMDCs were stimulated by transfecting 2.5 g/ml of A. fumigatus DNA or E.
coli DNA that was left untreated (DNA) or treated with the CpG methyltransferase M.SssI (Meth DNA), MspI, or HpaII. CpG 1826 at 3 g/ml
served as a positive control, while unstimulated cells and GpC 2137 were negative controls. After 24 h, supernatants were collected and TNF-
(A) and IL-12p70 (B) concentrations were determined by ELISA. Data are means  SE of five individual experiments. P was 	0.001 according
to one-way ANOVA with a Bonferroni posttest for TNF- and IL-12p70 stimulated by untreated A. fumigatus or E. coli DNA compared with any
treatment.
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detected than with untreated DNA. However, neither un-
treated nor methylated A. fumigatus stimulated TNF- release
from TLR9/ BMDCs.
DNA from A. fumigatus stimulates the production of type I
IFN in human pDCs. Immunostimulatory CpG-rich motifs dif-
fer between mice and humans (8). Therefore, we next deter-
mined whether A. fumigatus DNA would also stimulate human
pDCs, a cell type which highly expresses TLR9 (30). A. fumi-
gatus DNA stimulated IFN- production in human pDCs ob-
tained from seven different donors (Fig. 4A) in a dose-depen-
dent fashion (Fig. 4B). As was observed with murine dendritic
cells, cytokine production was significantly decreased if the
DNA was methylated.
ODNs containing CpG-rich motifs present in the A. fumi-
gatus genome stimulate signaling and cytokine responses in a
TLR9-dependent fashion. Next, we took advantage of the
nearly complete (98.0%) deciphering of the A. fumigatus ge-
nome to determine the GC content of the genome and to
search for putative immunostimulatory CpG-rich motifs in A.
fumigatus DNA. The GC content of the sequenced portion of
the A. fumigatus genome was determined to be 49.8%. More-
over, the percentage of CpG dinucleotide sequences was
5.35%. Using the conservative search criteria described in Ma-
terials and Methods, 23 and 87 potential murine and human
immunostimulatory motifs were identified, respectively (see
Table S1 in the supplemental material). Samples of these ODNs
were then synthesized on a phosphothiorate background and
tested for their capacity to stimulate murine BMDCs and human
TLR9-transfected HEK293 cells.
The six synthesized ODNs containing murine-like motifs
stimulated BMDCs derived from WT mice to secrete TNF-,
although there was considerable variation in their stimulatory
capacities (Fig. 5A). The most potent of the ODNs, mAF2 and
mAF5, stimulated TNF- concentrations that were nearly as
high as that seen with CpG 1826. In contrast, cytokine levels
stimulated by mAF3 and mAF6 were barely above the back-
ground. None of the ODNs stimulated cytokine release from
TLR9/ BMDCs above background levels (Fig. 5B).
Next, ODNs representing human-like CpG motifs were as-
sessed for their capacity to stimulate HEK293 cells stably co-
transfected with hTLR9 and an NF-B-driven luciferase re-
porter gene. All ODNs tested induced luciferase activity, with
the level of activity generally increasing in a dose-dependent
manner (Fig. 6). As was observed with the murine-like motifs,
the stimulatory capacities of the individual ODNs were quite
variable. hAF1, which occurs nine times in the A. fumigatus
genome, was at least as potent as the positive control, CpG
2007. The control ODN, GpC 2137, did not induce the activa-
tion of the TLR9-transfected cells. The ODNs tested in Fig. 6
did not induce significant luciferase activity in HEK293 cells
stably transfected with hTLR7 and an NF-B-driven luciferase
reporter gene (data not shown).
FIG. 3. A. fumigatus DNA stimulates TNF- secretion in a
TLR9-dependent manner. BMDCs from WT and TLR9/ mice
were transfected with the indicated concentrations of A. fumigatus
DNA that was left untreated (Af DNA) or treated with the CpG
methyltransferase M.SssI (Met Af DNA) and incubated at 37°C.
After 24 h, supernatants were collected and TNF- concentrations
were determined by ELISA. The concentrations of TNF- released
from unstimulated WT and TLR9/ BMDCs were 225  40 pg/ml
and 134  18 pg/ml, respectively. Data are means  SE of a
representative (out of four) experiment performed in triplicate. P
was 	0.001 according to one-way ANOVA with a Bonferroni post-
test for TNF- stimulated by Af DNA in WT BMDCs compared
with any other group at DNA concentrations of 3 and 10 g/ml. DC,
dendritic cells; KO, knockout.
FIG. 4. Stimulation of human pDCs by A. fumigatus DNA. Human
pDCs were isolated from PBMCs by positive selection using CD304
magnetic beads. (A) pDCs were stimulated with 10 g of A. fumigatus
DNA which was either left untreated or methylated with the CpG
methyltransferase M.SssI. Unstimulated and CpG 2336 (10 g/ml)-
stimulated pDCs served as negative and positive controls, respectively.
After 18 to 24 h, supernatants were collected and analyzed by ELISA
for IFN-. Results are shown as means  SE of seven individual
donors. P was 	0.001 comparing untreated and methylated DNA by
one-way ANOVA with a Bonferroni posttest. (B) As in panel A, except
a dose-response curve was performed comparing untreated and meth-
ylated A. fumigatus DNA. Data are means  SE of a representative
(out of three) experiment performed in triplicate. P was 	0.001 com-
paring untreated and methylated DNA at concentrations of 1, 3, and
10 g/ml by two-way ANOVA with a Bonferroni posttest.
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DISCUSSION
Innate immunity plays a critical role in microbial defenses by
allowing the host to rapidly respond to a challenge and by
providing a bridge to adaptive immunity. The strong associa-
tion of invasive aspergillosis with qualitative and quantitative
disorders of phagocyte function suggests that innate recogni-
tion of Aspergillus spp. is of particular importance in defending
against these ubiquitous fungi. Previous studies by our labora-
tory and others have demonstrated that following incubation of
phagocytes with A. fumigatus conidia and hyphae, TLR2- and
TLR4-dependent signaling cascades are stimulated, leading to
proinflammatory cytokine production (6, 19, 21, 25, 26). Here,
we demonstrate a putative contribution of another TLR,
TLR9, to defenses against aspergillosis.
Whereas the ligands for TLR2 and TLR4 on A. fumigatus
remain undefined, several lines of evidence establish unmethy-
lated CpG-rich fungal DNA as the ligand for TLR9. First,
using restriction endonucleases and DNA methylases, the
presence of unmethylated CpG sequences (the natural ligand
for TLR9) in A. fumigatus DNA was demonstrated. Second,
stimulation of murine DC from TLR9/ mice with A. fumi-
gatus DNA resulted in greatly impaired cytokine production
FIG. 5. Stimulation of murine BMDCs by ODNs containing CpG-rich motifs present in the A. fumigatus genome. BMDCs from WT (top panel)
and TLR9/ (bottom panel) mice were stimulated with the indicated mouse-like CpG motifs (see Table S1 in the supplemental material). CpG
1826 served as a positive control, while unstimulated (Unstim) cells and GpC 2137 were negative controls. After 24 h, supernatants were collected
and TNF- concentrations were determined by ELISA. Data are means SE of a representative (out of three) experiment performed in triplicate.
FIG. 6. Stimulation of hTLR9-transfected HEK293 cells by ODNs containing CpG-rich motifs present in the A. fumigatus genome. HEK293
cells stably coexpressing hTLR9 and the NF-B-driven luciferase reporter construct were stimulated with the indicated human-like CpG motifs
(see Table S1 in the supplemental material). CpG 2007 served as a positive control, while GpC 2137 was a negative control. After 18 h, luciferase
activity was determined in the cell lysates. Results are expressed as n-fold induction over unstimulated cells. Data are means  SE of a
representative (out of four) experiment performed in triplicate.
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compared with that seen with WT DC. Nevertheless, the pos-
sibility that some stimulation induced by the A. fumigatus DNA
was due to mechanisms independent of TLR9 cannot be ex-
cluded. DC from TLR9/ mice did secrete some residual
TNF- after treatment with A. fumigatus DNA. Similarly, some
residual cytokine secretion was observed after stimulation of
WT DC with methylated DNA. This residual response could
be due to other intracellular DNA sensors, including DAI
(DNA-dependent activator of IFN-regulatory factors) (29) and
an as-yet-unidentified sensor dependent on TANK-binding ki-
nase 1 (10).
In a survey of 15 bacterial species, the immunostimulatory
capacity of bacterial DNA samples directly correlated with the
frequency of CpG dinucleotides (7). In that study, the CpG
frequency ranged from 1.44% to 12.21%. Our analysis of the A.
fumigatus genome determined the frequency of CpG dinucle-
otides sequences to be 5.35%, similar to that of bacterial DNA.
Mammalian DNA is thought to be less immunostimulatory
than bacterial DNA because the frequency of the CpG motif is
suppressed. In addition, mammalian, but not bacterial, DNA is
highly methylated (1). Although mammals and fungi share
membership in the eukaryotic kingdom, we found that CpG
motifs in A. fumigatus DNA had a low level of methylation.
Thus, the pattern of degradation of A. fumigatus DNA follow-
ing treatment with HpaII, an endonuclease specific for un-
methylated CCGG sequences, was similar to the pattern seen
after treatment with MspI, an endonuclease which cleaves both
methylated and unmethylated CCGG sequences. Consistent
with these findings, A. fumigatus DNA stimulated dendritic cell
cytokine responses comparable to those stimulated by E. coli
DNA, which has a CpG frequency of 7.27%.
An in silico genome-wide analysis of the fungal DNA dem-
onstrated the abundant presence of CpG-rich motifs of the
type predicted to be stimulatory for mouse and human TLR9.
The analysis was conservative and additional stimulatory mo-
tifs likely exist within the genome. Synthetic ODNs containing
CpG-rich motifs found in A. fumigatus DNA stimulated mouse
and human cells. Interestingly, of the synthetic ODNs tested,
the one that was most stimulatory had a sequence which ap-
peared the most often in the A. fumigatus genome. The poten-
tial for this ODN to be used as an immunostimulant in humans
should be considered given that it stimulated human cells as
well as a CpG-rich ODN that is undergoing clinical trials.
The relative contribution of A. fumigatus DNA to the im-
munology of human aspergillosis remains to be determined.
Future studies will examine the conditions under which DNA
is released from the fungal cell, an event that presumably
would be a prerequisite for an interaction with TLR9 to occur.
In addition, in its tissue-invasive hyphal phase, A. fumigatus is
mostly an extracellular pathogen and TLR9 is located intra-
cellularly in the endosomal compartments. Nevertheless, dis-
parities between WT and TLR9/ mice with regards to their
susceptibilities to aspergillosis (3) suggest that the interaction
of A. fumigatus DNA and TLR9 occurs in vivo. In addition, a
recent study examined variants in TLR genes in a population
of Italian children with hematological malignancies (15). The
frequency of the C allele of the TLR9 T-1486C polymorphism
was significantly higher in patients with invasive mold infec-
tions than in patients without invasive fungal infections. Fur-
thermore, a recent study (5) found an association of the TLR9
T-1237C polymorphism with allergic bronchopulmonary as-
pergillosis, a form of aspergillosis mainly found in patients that
suffer from asthma and cystic fibrosis.
An inflammatory response is beneficial to the host if it en-
ables the host to contain or eliminate the pathogen. However,
the immune response can be detrimental if it results in damage
to host tissues. The finding that TLR9/ mice survived longer
than WT mice following challenge with A. fumigatus suggests
that, at least in some circumstances, the response to A. fumi-
gatus DNA favors the pathogen rather than the host. The nature
of the immune response might be important too. In addition to
direct inflammatory effects resulting from stimulation of proin-
flammatory cytokines, including type I IFNs, CpG-rich DNA
biases toward Th1-type responses (13). Finally, while our stud-
ies focused upon A. fumigatus, it is likely that DNA from other
medically important fungi also contain unmethylated CpG-rich
motifs capable of stimulating immune responses.
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